

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 122.15 | 103.45 | 93.70 | 80.70 | 62.19 |
| Total Expenses | 134.39 | 102.80 | 97.09 | 78.69 | 68.92 |
| Profit Before Tax | -12.24 | 0.66 | -0.56 | 2.80 | -6.74 |
| Profit After Tax | -13.96 | -0.56 | -0.43 | 2.39 | -4.84 |
| Operating Profit After Depreciation | -8.15 | 6.69 | 1.43 | 8.53 | -0.42 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 46.80 | 40.82 | 46.43 | 44.03 | 32.75 |
| Total Non Current Assets | 87.99 | 76.98 | 80.65 | 73.17 | 70.83 |
| Total Current Assets | 40.77 | 56.21 | 34.07 | 37.15 | 43.65 |
| Total Assets | 128.76 | 133.19 | 114.72 | 110.32 | 114.49 |
| Total Shareholder's Fund | 9.49 | 18.66 | 5.58 | 6.11 | 3.40 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 4.83 | -0.96 | 9.86 | -0.50 | 7.43 |
| Net Cash Used In Investing Activities | -14.77 | -0.45 | -7.22 | -1.91 | -1.44 |
| Net Cash Used In Financing Activities | -9.48 | 19.83 | -1.14 | -13.27 | 6.20 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 77.86 | 71.04 | 63.36 | 56.10 | 43.37 |
| Total Expenses | 91.34 | 71.21 | 63.82 | 54.87 | 49.95 |
| Profit Before Tax | -13.48 | -0.17 | 2.37 | 1.23 | -6.58 |
| Profit After Tax | -13.78 | 0.05 | 2.89 | 0.89 | -4.95 |
| Operating Profit After Depreciation | -9.57 | 5.23 | 3.98 | 7.12 | -0.53 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 31.45 | 27.80 | 30.32 | 27.96 | 26.43 |
| Total Non Current Assets | 48.62 | 71.44 | 72.73 | 68.31 | 68.43 |
| Total Current Assets | 70.27 | 44.79 | 25.97 | 23.39 | 27.80 |
| Total Assets | 118.89 | 116.22 | 98.70 | 91.70 | 96.23 |
| Total Shareholder's Fund | 25.13 | 32.78 | 14.53 | 11.28 | 10.04 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 2.28 | -5.30 | 9.12 | 8.75 | -0.91 |
| Net Cash Used In Investing Activities | -6.48 | -0.54 | -5.32 | 0.83 | -2.10 |
| Net Cash Used In Financing Activities | -11.93 | 20.59 | -2.27 | -10.52 | 2.18 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 34.74 | 32.96 | 34.84 | 28.61 | 31.32 |
| Total Expenses | 41.84 | 34.47 | 39.79 | 32.80 | 41.46 |
| Profit Before Tax | -7.98 | -4.37 | -6.82 | 2.81 | -13.81 |
| Profit After Tax | -7.40 | -4.60 | -6.36 | 2.03 | -15.37 |
| Operating Profit after Depreciation | -5.19 | -0.38 | -3.25 | 5.28 | -9.41 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 24.57 | 22.07 | 21.29 | 17.57 | 19.35 |
| Total Expenses | 35.05 | 24.13 | 26.32 | 22.99 | 30.34 |
| Profit Before Tax | -8.99 | -3.64 | -5.86 | 2.58 | -10.89 |
| Profit After Tax | -7.93 | -3.47 | -5.40 | 2.07 | -11.86 |
| Operating Profit after Depreciation | -5.78 | -1.08 | -2.77 | 4.58 | -6.62 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
No data available
On 25 May 2026
22 May 2026, 11:37 am
On 25 March 2026
23 Mar 2026, 09:44 am
On 14 March 2026
14 Feb 2026, 03:25 pm
On 12 February 2026
10 Feb 2026, 04:15 pm
On 14 November 2025
12 Nov 2025, 09:51 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.